New drug trials to begin for treating hospitalized COVID patients
The World Health Organization (WHO) says three drugs already used for other conditions will be used to treat hospitalized COVID-19 patients as part of the global Solidarity PLUS trial program. The three drugs – artesunate, imatinib and infliximab – were chosen by an independent panel of experts looking to find…